Centessa Pharmaceuticals Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
25 Sep 24 | SellUS$260,724 | Gregory Weinhoff | Individual | 16,619 | US$15.69 |
Insider Trading Volume
Insider Buying: 0ACX insiders have only sold shares in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
State or Government | 0 | 0% |
Private Companies | 27,500 | 0.0214% |
Individual Insiders | 2,492,534 | 1.94% |
General Public | 29,533,183 | 23% |
VC/PE Firms | 39,606,764 | 30.8% |
Institutions | 56,908,551 | 44.3% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 32%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
19,963,157 | US$319.2m | 0% | 60.62% | |||
9,961,789 | US$159.3m | 0% | 9.69% | |||
9,681,818 | US$154.8m | 0% | 2.52% | |||
5,714,404 | US$91.4m | 1.7% | 2.83% | |||
4,780,560 | US$76.4m | 59.2% | 5.78% | |||
4,364,366 | US$69.8m | 47.5% | 0.01% | |||
3,933,307 | US$62.9m | 27.6% | 1.36% | |||
3,931,818 | US$62.9m | 0% | 39.91% | |||
3,125,000 | US$50.0m | 38.9% | 0.09% | |||
2,890,816 | US$46.2m | 41.7% | 3.86% | |||
2,787,194 | US$44.6m | 0% | no data | |||
2,345,075 | US$37.5m | 13.8% | 5.89% | |||
2,112,500 | US$33.8m | 49.6% | 0.79% | |||
2,092,011 | US$33.5m | 89.5% | 0.21% | |||
2,049,548 | US$32.8m | -4.09% | no data | |||
1,996,000 | US$31.9m | 438% | 0.19% | |||
1,788,077 | US$28.6m | -23.3% | 0.07% | |||
1,611,600 | US$25.8m | 187% | 1.3% | |||
1,245,000 | US$19.9m | 0% | 3.97% | |||
1,156,723 | US$18.5m | 0% | 0.01% | |||
1,135,702 | US$18.2m | 36.7% | 2.93% | |||
1,023,122 | US$16.4m | 302% | 0.04% | |||
935,151 | US$15.0m | 1.3% | 0.01% | |||
870,190 | US$13.9m | 0.61% | no data | |||
724,348 | US$11.6m | 73.6% | no data |